Novel fungal metabolites as cell wall active antifungals: fermentation, isolation, physico-chemical properties, structure and biological activity

Two novel antifungal compounds, 1 (SCH 466457), and 2 (SCH 466456), active in a "cell wall" assay, were isolated from the fermentation broth of an unidentified fungus. The active compounds were separated from the broth filtrate by adsorption on a macroreticular resin and were purified on reverse phase HPLC. Detailed mass spectrometric and NMR experiments and degradative studies helped in elucidating the structures of these compounds. The compounds were identified to be peptides containing amino acids such as alanine, aminoisobutyric acid, proline, leucine, valine, glycine and a previously identified beta-keto acid, 2-methyl 3-oxotetradecanoic acid. (5) Both compounds were active against Candida, dermatophytes and Aspergillus (Geometric Mean MIC's, 8.9, 20 and 16 microg/ml, and 64, 128 and 23 microg/ml, respectively for 1 and 2).

SCH 45752--an inhibitor of calmodulin-sensitive cyclic nucleotide phosphodiesterase activity

A highly potent inhibitor of calmodulin-sensitive phosphodiesterase (PDE) activity was isolated from the culture broth of an unidentified fungal isolate, SCF-125. A chemically defined medium was developed for production of this compound. The PDE inhibitor was isolated from the fermentation filtrate by adsorption on a macro-reticular resin and further purified by gel filtration chromatography and reverse-phase HPLC. The major PDE inhibitor was identified as cephalochromin, a bis-naphthopyrone, by spectral data analysis. The compound, SCH 45752, inhibited calmodulin-sensitive PDE activities with IC50 values of 40-47 nM. It inhibited the activities of calmodulin-independent PDE and various protein kinases with higher IC50 values (2-40 microM). SCH 45752 does not appear to be a calmodulin antagonist. Furthermore, SCH 45752 affects smooth muscle contraction at a concentration of 30 microM; it potentiated the relaxing effect of sodium nitroprusside on carotid artery media contracted by histamine. Thus SCH 45752 is one of the most potent inhibitors of calmodulin-sensitive PDE activity known, and it is capable of exerting a pharmacological effect in at least one intact tissue model.

Macrolactams: two novel homologous series of compounds produced by Actinomadura sp. SCC 1778

Eight antifungal compounds were identified from the fermentation of Actinomadura sp. SCC 1778. This culture produces four homologous compounds (C22H42N2O5 approximately C25H48N2O5) containing the sugar, mycosamine, and four homologous compounds (C22H42N2O5 approximately C25H48N2O5) containing the sugar, 3,6-dideoxy-3-amino-L-talopyranose. Five of the compounds identified were novel macrolactams. All these compounds exhibit antifungal activity against Candida spp. with geometric mean MICs ranging from approximately 1.0 micrograms/ml for the higher homologs to 30 micrograms/ml for the lower homologs.

Detection and confirmation of urinary cannabinoids

Both a thin layer chromatographic procedure (TOXI-LAB) and two homogeneous immunoassays with differing sensitivity limits (EMIT-st, and EMIT d.a.u.) were used to test 525 urine specimens for metabolites of tetrahydrocannabinol. Negative results were obtained by all techniques for 283 specimens. The EMIT-st was positive for 184 specimens, the EMIT-d.a.u. for 47 additional specimens. The TOXI-LAB results were positive for all these 231 specimens. An additional 11 specimens were positive by EMIT-d.a.u. and negative by TOXI-LAB. Gas chromatography/mass spectrometry analyses of five of these 11 indicated that their average 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentration was 7.4 +/- 2.2 ng/mL, well below the lower detection limit of the TOXI-LAB procedure. Using both EMIT-d.a.u. and TOXI-LAB assures a reliable urinary cannabinoid analysis above a concentration of 25 ng/mL.